menu
    • menu

    Company profile for H3 Biomedicine Inc

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    H3 Biomedicine is a leading company in cancer genomics based drug discovery, delivering on the promise of precision medicine. The company was launched in 2011 with an unprecedented $200 million funding commitment from Eisai plus additional funding for clinical programs. As a clinical-stage biopharmaceutical company, we uniquely leverage our distinct insights from cancer genomics and real-life patient data to advance our projec...
    H3 Biomedicine is a leading company in cancer genomics based drug discovery, delivering on the promise of precision medicine. The company was launched in 2011 with an unprecedented $200 million funding commitment from Eisai plus additional funding for clinical programs. As a clinical-stage biopharmaceutical company, we uniquely leverage our distinct insights from cancer genomics and real-life patient data to advance our projects to clinical proof of concept and beyond.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    H3 Biomedicine IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Technology Square, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.h3biomedicine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai shutters oncology unit, cuts around 80 jobs
    Eisai shutters oncology unit, cuts around 80 jobs

    19 Jul 2022

    // Nicole DeFeudis ENDPTS

    https://endpts.com/eisai-shutters-oncology-unit-cuts-around-80-jobs/

    Nicole DeFeudis ENDPTS
    19 Jul 2022
    Share Share
    H3 Biomedicine Presents Update on Intratumoral E7766 Clinical Program
    H3 Biomedicine Presents Update on Intratumoral E7766 Clinical Program

    08 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211008005045/en

    BUSINESSWIRE
    08 Oct 2021
    Share Share
    H3 Biomedicine Presents Data Update on H3B-6545 for Treatment of Locally
    H3 Biomedicine Presents Data Update on H3B-6545 for Treatment of Locally

    08 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201208005168/en/H3-Biomedicine-Inc.-Presents-Data-Update-on-H3B-6545-for-Treatment-of-Locally-Advanced-or-Metastatic-Estrogen-Receptor-positive-HER2-negative-Breast-Cancer-at-San-Antonio-Breast-Cancer-Symposium

    BUSINESSWIRE
    08 Dec 2020
    Share Share
    H3 Biomedicine, Inc. Presents Data Update on H3B-6545 for Treatment of Locally
    H3 Biomedicine, Inc. Presents Data Update on H3B-6545 for Treatment of Locally

    08 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201208005168/en

    BUSINESSWIRE
    08 Dec 2020
    Share Share
    Eisai’s H3 Biomedicine appoints new CMO
    Eisai’s H3 Biomedicine appoints new CMO

    24 Feb 2020

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/26/15482/eisais-h3-biomedicine-appoints-new-cmo.html

    BIOSPECTRUMASIA
    24 Feb 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search